Biomaterials

Global Biomaterials Market to Reach US$215.6 Billion by 2030

The global market for Biomaterials estimated at US$113.5 Billion in the year 2024, is expected to reach US$215.6 Billion by 2030, growing at a CAGR of 11.3% over the analysis period 2024-2030. Metallic, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$119.1 Billion by the end of the analysis period. Growth in the Polymeric segment is estimated at 12.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.1 Billion While China is Forecast to Grow at 15.0% CAGR

The Biomaterials market in the U.S. is estimated at US$29.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$51.4 Billion by the year 2030 trailing a CAGR of 15.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Biomaterials Market – Key Trends & Drivers Summarized

What is Driving Innovation in the Biomaterials Market?

Biomaterials, a class of substances engineered to interact with biological systems, are at the forefront of medical, pharmaceutical, and technological innovations. From wound healing and drug delivery to artificial organs and prosthetics, biomaterials have revolutionized healthcare. The development of advanced biomaterials, such as biodegradable polymers, bioactive ceramics, and nanomaterials, is transforming how medical devices are designed, produced, and integrated with the human body. The intersection of material science with biotechnology has led to the creation of materials that can not only be biocompatible but also promote tissue regeneration and support cell growth. Emerging technologies such as 3D printing are further propelling innovation, allowing the creation of customized implants and prosthetics with unprecedented precision and functionality. The global shift towards personalized medicine and regenerative therapies has positioned biomaterials as a critical component in the future of healthcare, offering solutions that improve patient outcomes and extend the capabilities of medical interventions.

How Are End-Use Applications Shaping the Future of Biomaterials?

Biomaterials are finding a wide range of applications across various sectors, with healthcare being the primary driver of demand. In orthopedics, biomaterials are widely used in joint replacements, bone grafts, and spinal implants, where materials such as titanium and bioresorbable polymers support bone healing and regeneration. Dental implants, which require both strength and biocompatibility, increasingly rely on advanced biomaterials like zirconia and composite resins. Beyond orthopedics and dentistry, biomaterials are making significant strides in cardiovascular medicine. Stents, heart valves, and vascular grafts are now being produced from bioactive materials that reduce the risk of thrombosis and improve the longevity of the implants. Additionally, tissue engineering and wound care are two growing fields where biomaterials play a pivotal role, with new materials being designed to enhance cellular responses, promote faster healing, and reduce scarring. The demand for bioabsorbable and biocompatible materials is also increasing in drug delivery systems, where these materials help control the release and targeting of therapeutic agents, ensuring higher efficacy and reduced side effects.

What Role Does Technology Play in Advancing Biomaterial Capabilities?

Technological advancements are driving the biomaterials market into new frontiers, particularly through the use of nanotechnology, biotechnology, and smart materials. Nanotechnology has opened the door to nanoscale biomaterials that can interact with biological tissues on a cellular level, enhancing their integration and performance in the body. These nanomaterials are proving to be game-changers in fields like drug delivery, where nanoparticles can be designed to target specific cells or tissues, delivering drugs more efficiently and reducing systemic side effects. Similarly, 3D printing is revolutionizing the way biomaterials are used in healthcare, enabling the production of highly customized implants, prosthetics, and even organ scaffolds that are tailored to individual patient anatomies. Biotechnology is further enhancing the capabilities of biomaterials, with innovations in genetic engineering and tissue scaffolding paving the way for bio-hybrid materials that blend synthetic and biological components. These smart biomaterials can adapt to changes in the body, such as pH, temperature, or chemical signals, making them highly effective in dynamic biological environments. These technological breakthroughs are not only improving the performance of biomaterials but also expanding their applications into areas previously thought impossible.

What Factors Are Driving Growth in the Biomaterials Market?

The growth in the biomaterials market is driven by several factors, including technological advancements, expanding medical applications, and shifting consumer expectations. One of the primary drivers is the increasing prevalence of chronic diseases such as osteoarthritis, cardiovascular diseases, and diabetes, which require advanced biomaterial-based implants, prosthetics, and drug delivery systems. The aging global population is also a significant growth driver, as older individuals are more likely to need orthopedic implants, dental restorations, and cardiovascular devices, all of which depend on cutting-edge biomaterials. Additionally, consumer demand for minimally invasive procedures and faster recovery times is pushing the adoption of biomaterials that promote better integration with the body and enhance healing processes. Technological advancements in areas such as nanotechnology, tissue engineering, and 3D printing are enabling the creation of next-generation biomaterials that offer superior performance and customization. Regulatory support and government funding for research and development in biomaterials, especially for medical and healthcare applications, are further fueling market growth. Moreover, as healthcare systems globally shift towards personalized medicine and regenerative therapies, the demand for bioengineered materials that can be tailored to individual patient needs continues to expand, driving both innovation and market expansion in the biomaterials sector.

SCOPE OF STUDY:

The report analyzes the Biomaterials market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Metallic, Polymeric, Ceramic, Natural); Application (Orthopedic, Cardiovascular, Drug Delivery System, Dental, Neurological Disorder, Ophthalmology, Plastic Surgery, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 123 Featured) -

• Aran Biomedical
• BASF SE
• Berkeley Advanced Biomaterials, Inc.
• Biomomentum Inc.
• Blafar Ltd.
• Bonegraft (Powerbone)
• Cam Bioceramics BV
• Celanese Corporation
• Ceraver
• Corbion NV

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs CBob geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.